Commission Implementing Decision (EU) 2015/1213 of 22 July 2015 authorising extension of uses of flavonoids from Glycyrrhiza glabra L. as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2015) 4968)

Flavonoids from Glycyrrhiza glabra L. (hereinafter referred to as ‘Glavonoid’), as specified in Annex I may be placed on the market in the Union as a novel food ingredient for the uses specified in Annex II without prejudice to the provisions of Directive 96/8/EC and Directive 1999/21/EC. Glavonoid shall not be sold to the final consumer as such.

1 The designation of Glavonoid authorised by this Decision on the labelling of the foodstuffs containing it shall be ‘flavonoids from Glycyrrhiza glabra L.’.

2 There shall be a statement on the labelling of the foods where the product was added as a novel food ingredient indicating that: (a) the product should not be consumed by pregnant and breast feeding women, children and young adolescents; and (b) people taking prescription drugs should only consume the product under medical supervision; (c) a maximum of 120 mg of Glavonoid per day should be consumed.

3 The amount of Glavonoid in the final food shall be indicated on the labelling of the food containing it.

4 Beverages containing Glavonoid shall be presented to the final consumer as single portions.

This Decision is addressed to Kaneka Pharma Europe NV Triomflaan 173, 1160 Brussels, Belgium.